Earnings calendar/BDRX
Biodexa Pharmaceuticals Plc (BDRX)
Next report date and post-earnings actuals — standardized metrics from the filed statements. No analyst estimates, no narrative, no price targets.
Pre-earnings
The next report date (from the company's filing cadence) and how the business has been running.
No upcoming estimate row on the calendar. Showing run-rate from recent prints only.
Latest EPS YoY
+90.9%
vs 2025-04-11
Latest revenue YoY
—
How results look so far
Trailing revenue (avg 4Q)
—
Printed quarters
EPS beat rate (4Q)
50%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Mar 27, 2026
EPS beat
EPS actual / est
$-0.00 / $-0.01
+90.9%
Revenue actual / est
— / —
—
Result
Target reached
EPS vs prior estimate, when one exists
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 3/27/2026 | $-0.01 | $-0.00 | +90.9% | — | Pending | — |
| 9/12/2025 | $-0.00 | $-0.00 | +92.5% | — | Pending | — |
| 4/11/2025 | $-0.01 | $-0.01 | -4.8% | $16,606 | Pending | — |
| 9/26/2024 | $-0.22 | $-0.34 | -49.9% | $16,606 | Pending | — |
| 4/19/2024 | $-3.54 | $-3.54 | -0.1% | $105,788 | $106,020 | +0.2% |
| 9/15/2023 | — | $-2773.25 | — | — | $377,365 | — |
| 4/28/2023 | — | $-36466.51 | — | — | $283,915 | — |
| 9/14/2022 | — | $-23986.03 | — | — | $568,090 | — |
| 4/26/2022 | — | $-20085.44 | — | — | $238,759 | — |
| 9/17/2021 | — | $-28132.36 | — | — | $554,080 | — |
| 6/30/2021 | — | $-28.14 | — | — | $554,080.41 | — |
| 4/30/2021 | — | $-41881.99 | — | — | $238,043 | — |
| 12/31/2020 | — | $-41.88 | — | — | $238,043.14 | — |
| 12/30/2020 | — | $-41.88 | — | — | $238,043.14 | — |
| 9/10/2020 | — | $-16467.20 | — | — | $216,132 | — |
| 12/31/2019 | — | $-195.27 | — | — | $284,553.07 | — |
| 9/30/2019 | — | $-492.92 | — | $651,000 | $557,000 | -14.4% |
| 4/24/2019 | — | $-4081252.19 | — | — | $1.9M | — |
| 6/30/2018 | — | $-2384.03 | — | — | $721,255.52 | — |
| 12/31/2017 | — | $-2460.82 | — | — | $693,687.7 | — |